Stock Analiz

Natural Alternatives International Inc. NAII

Medicinal Chemicals and Botanical Products · data as of November 13, 2026

$0.97Market cap $6M
Open the interactive analysis →

Natural Alternatives International Inc. (NAII) is a healthcare company listed in the US with a market value of about $6M. In the twelve months to September 30, 2026 it had revenue of $133M and net income of -$23M, a net margin of -17.2%.

Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is value (1/5); the weakest is future growth (0/5).

Key numbers: 5-year revenue growth of -4% a year, a 5-year average ROIC of -2%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 287% above the current price.

About Natural Alternatives International

Natural Alternatives International is listed in the US and classified in medicinal chemicals and botanical products. Revenue went from $80M in 2015 to $143M in 2026, growth of about 5.4% a year. It was profitable in 6 of the last 10 years in our data. Its share count rose by 3% over three years (dilution for shareholders). It spends 2% of revenue on research and development.

Score: 0.4 / 5

Value1/5
Future growth0/5
Track record0/5
Financial health0/5
Shareholder returns1/5

Checks passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.0
P/B0.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-109.6%
Shareholder yield1.5%
Intrinsic value vs. price+287%

Growth and quality

Revenue growth (1 yr)9.8%
Revenue growth (5 yrs, per year)-4.4%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-4.7%
ROIC (5-yr avg.)-2.5%
Profitable years (of last 10)6
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2026202520242023202220212020201920182017
Revenue$133M$143M$130M$114M$154M$171M$179M$119M$138M$132M$122M
Net income-$23M-$21M-$14M-$7M$3M$11M$11M-$2M$7M$5M$7M
Free cash flow-$7M-$13M$2M-$5M-$7M-$15M$16M-$850000$1M-$2M$9M
EPS (diluted)$-3.79$-3.43$-2.28$-1.23$0.43$1.74$1.69$-0.25$0.92$0.73$1.09
Net margin-17.2%-14.5%-10.4%-6.3%1.6%6.3%6.0%-1.4%4.7%3.8%5.9%
ROIC—-14.7%-5.4%-4.7%3.0%9.3%12.6%-1.4%5.1%11.0%11.3%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Natural Alternatives International stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 287% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Natural Alternatives International pay a dividend?

Not currently.

Is Natural Alternatives International a good stock to buy?

We do not give buy or sell advice. Natural Alternatives International scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.